CT radiomics based on different machine learning models for classifying gross tumor volume and normal liver tissue in hepatocellular carcinoma
Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. Methods We recruited...
Saved in:
Published in | Cancer imaging Vol. 24; no. 1; pp. 20 - 9 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
26.01.2024
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1470-7330 1740-5025 1470-7330 |
DOI | 10.1186/s40644-024-00652-4 |
Cover
Abstract | Background & aims
The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model.
Methods
We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison.
Results
Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973–0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835– 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively).
Conclusion
CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms. |
---|---|
AbstractList | Background & aims
The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model.
Methods
We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison.
Results
Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973–0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835– 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively).
Conclusion
CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms. Background & aimsThe present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model.MethodsWe recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison.ResultsSeven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973–0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835– 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively).ConclusionCT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms. The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms. Abstract Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. Methods We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Results Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973–0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835– 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). Conclusion CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms. The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms. Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model. Methods We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison. Results Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively). Conclusion CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms. Keywords: CT radiomics, Hepatocellular carcinoma, Automatic classification, Machine learning The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model.BACKGROUND & AIMSThe present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular carcinoma by mainstream machine learning methods, aiming to establish an automatic classification model.We recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison.METHODSWe recruited 104 pathologically confirmed hepatocellular carcinoma patients for this study. GTV and normal liver tissue samples were manually segmented into regions of interest and randomly divided into five-fold cross-validation groups. Dimensionality reduction using LASSO regression. Radiomics models were constructed via logistic regression, support vector machine (SVM), random forest, Xgboost, and Adaboost algorithms. The diagnostic efficacy, discrimination, and calibration of algorithms were verified using area under the receiver operating characteristic curve (AUC) analyses and calibration plot comparison.Seven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively).RESULTSSeven screened radiomics features excelled at distinguishing the gross tumor area. The Xgboost machine learning algorithm had the best discrimination and comprehensive diagnostic performance with an AUC of 0.9975 [95% confidence interval (CI): 0.9973-0.9978] and mean MCC of 0.9369. SVM had the second best discrimination and diagnostic performance with an AUC of 0.9846 (95% CI: 0.9835- 0.9857), mean Matthews correlation coefficient (MCC)of 0.9105, and a better calibration. All other algorithms showed an excellent ability to distinguish between gross tumor area and normal liver tissue (mean AUC 0.9825, 0.9861,0.9727,0.9644 for Adaboost, random forest, logistic regression, naivem Bayes algorithm respectively).CT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms.CONCLUSIONCT radiomics based on machine learning algorithms can accurately classify GTV and normal liver tissue, while the Xgboost and SVM algorithms served as the best complementary algorithms. |
ArticleNumber | 20 |
Audience | Academic |
Author | Zhang, Huai-wen Wang, Yi-ren Huang, De-long Zhong, Hao-shu Pang, Hao-wen |
Author_xml | – sequence: 1 givenname: Huai-wen surname: Zhang fullname: Zhang, Huai-wen organization: Department of Radiotherapy, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, Department of Oncology, The third people’s hospital of Jingdezhen, The third people’s hospital of Jingdezhen affiliated to Nanchang Medical College – sequence: 2 givenname: De-long surname: Huang fullname: Huang, De-long organization: School of Clinical Medicine, Southwest Medical University – sequence: 3 givenname: Yi-ren surname: Wang fullname: Wang, Yi-ren organization: School of Nursing, Southwest Medical University – sequence: 4 givenname: Hao-shu surname: Zhong fullname: Zhong, Hao-shu email: 164678062@qq.com organization: Department of Hematology, Huashan Hospital, Fudan University – sequence: 5 givenname: Hao-wen surname: Pang fullname: Pang, Hao-wen email: haowenpang@foxmail.com organization: Department of Oncology, The Affiliated Hospital of Southwest Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38279133$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ktlq3DAUhk1JaZb2BXpRBIXSG6eSLMvyZRi6BAK9Sa_FsZYZDbI0lexAXqLPXHkmaRZKEELi8P2_lvOfVkchBlNV7wk-J0TwL5lhzliNaZmYt7Rmr6oTwjpcd02Djx7tj6vTnLcY01703ZvquBG060nTnFR_VtcogXZxdCqjAbLRKAaknbUmmTChEdTGBYO8gRRcWKMxauMzsjEh5SFnZ2-X8jrFnNE0j6V-E_08GgRBoxDTCB55d2MSmlzOs0EuoI3ZwRSV8X72UIwgKRfiCG-r1xZ8Nu_u1rPq17ev16sf9dXP75eri6tataKZaq1ahYFqa6jg2rZCMdBcQceZNoy1oAZoKGstZ0QDJUIQ24nBDrThWoNtzqrLg6-OsJW75EZItzKCk_tCTGsJaXLKG8lp17RGYUoAM9sOA9GD4BQPg9XFlRavzwevXYq_Z5MnObq8PA2CiXOWtCd9xzDGbUE_PkO3cU6hvLRQtOUc90Q8UGso57tg45RALabyohO0uNH9sef_ocrQpvSyJMW6Un8i-PRIsDHgp00unZpcDPkp-OHulvMwGv3ve-5TUwBxANTS9GSsVG6CxadcwXlJsFwCKg8BlSWgch9QyYqUPpPeu78oag6iXOCwNunh215Q_QWWdvgS |
CitedBy_id | crossref_primary_10_1016_j_engappai_2024_109452 crossref_primary_10_33192_smj_v77i2_271596 crossref_primary_10_1016_j_ejro_2024_100615 crossref_primary_10_3389_fonc_2024_1411214 crossref_primary_10_1186_s12885_024_13235_0 crossref_primary_10_1088_1361_6560_ad3cb1 crossref_primary_10_20935_AcadMed7444 crossref_primary_10_3390_cancers16061158 |
Cites_doi | 10.1016/j.ejmp.2021.05.009 10.1109/JTEHM.2019.2915534 10.3389/fonc.2022.650797 10.1038/s41598-020-63285-0 10.1109/MSP.2014.2347059 10.3389/fonc.2020.01621 10.1002/acm2.13024 10.1038/s41420-021-00634-6 10.1016/j.media.2021.102154 10.1002/mp.12602 10.1016/j.ejca.2011.11.036 10.1016/j.hpb.2019.11.002 10.1109/TPAMI.2016.2572683 10.1007/s00330-021-07877-y 10.1634/theoncologist.2019-IO-S1-s01 10.1007/s002689900215 10.1186/s13014-019-1392-z 10.1118/1.4871620 10.1007/s00330-020-06957-9 10.1002/mp.14320 10.1109/TIP.2019.2902784 10.1007/s00330-020-07641-8 10.3322/caac.21660 10.2174/1573405615666190503142031 10.1109/34.216733 10.1007/s00330-018-5787-2 10.1148/radiol.2017170554 10.1158/1078-0432.CCR-16-0460 10.1023/A:1011174803800 10.1111/apt.16563 10.3390/cancers14112798 10.1016/j.radonc.2021.03.030 10.1371/journal.pone.0205003 10.1002/bjs.5278 10.1002/mp.14131 10.3389/fmedt.2021.767836 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88C 88E 8FE 8FG 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH HCIFZ K9. M0S M0T M1P P5Z P62 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 DOA |
DOI | 10.1186/s40644-024-00652-4 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Central ProQuest Technology Collection ProQuest One ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Healthcare Administration Database Medical Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic DOAJ (Directory of Open Access Journals) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Technology Collection ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1470-7330 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_62735ec021a04f5bb1db8620bbfd1f72 A782197272 38279133 10_1186_s40644_024_00652_4 |
Genre | Journal Article |
GrantInformation_xml | – fundername: The Sichuan Provincial Medical Research Project Plan grantid: S21004 – fundername: The Open Fund for Scientific Research of Jiangxi Cancer Hospital grantid: 2021J15 |
GroupedDBID | --- 0R~ 1.S 29B 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FE 8FG 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS AQUVI ARAPS ASPBG AVWKF BAPOH BAWUL BCNDV BENPR BFQNJ BGLVJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ HCIFZ HMCUK HYE IAO IEA IHR IHW INH INR ITC KQ8 M0T M1P M48 OK1 P2P P62 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SOJ SV3 TR2 UKHRP WOQ AAYXX ALIPV CITATION NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 |
ID | FETCH-LOGICAL-c583t-dc5c0a2dfe286df58c4ad6ca764de445acba3245f641da21881f78bfb236ddaf3 |
IEDL.DBID | M48 |
ISSN | 1470-7330 1740-5025 |
IngestDate | Wed Aug 27 01:20:07 EDT 2025 Thu Sep 04 20:20:19 EDT 2025 Sat Jul 26 00:14:25 EDT 2025 Tue Jun 17 22:25:43 EDT 2025 Tue Jun 10 21:14:00 EDT 2025 Thu May 22 21:20:55 EDT 2025 Thu Apr 03 06:58:56 EDT 2025 Tue Jul 01 04:33:57 EDT 2025 Thu Apr 24 23:13:32 EDT 2025 Sat Sep 06 07:22:32 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Hepatocellular carcinoma Automatic classification CT radiomics Machine learning |
Language | English |
License | 2024. The Author(s). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c583t-dc5c0a2dfe286df58c4ad6ca764de445acba3245f641da21881f78bfb236ddaf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2925660918?pq-origsite=%requestingapplication% |
PMID | 38279133 |
PQID | 2925660918 |
PQPubID | 2040154 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_62735ec021a04f5bb1db8620bbfd1f72 proquest_miscellaneous_2919740005 proquest_journals_2925660918 gale_infotracmisc_A782197272 gale_infotracacademiconefile_A782197272 gale_healthsolutions_A782197272 pubmed_primary_38279133 crossref_citationtrail_10_1186_s40644_024_00652_4 crossref_primary_10_1186_s40644_024_00652_4 springer_journals_10_1186_s40644_024_00652_4 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-01-26 |
PublicationDateYYYYMMDD | 2024-01-26 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-26 day: 26 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Cancer imaging |
PublicationTitleAbbrev | Cancer Imaging |
PublicationTitleAlternate | Cancer Imaging |
PublicationYear | 2024 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | P Brodt (652_CR2) 2016; 22 CA Owens (652_CR33) 2018; 13 W Zhu (652_CR8) 2021; 7 N Maffei (652_CR34) 2021; 83 A Tang (652_CR18) 2018; 286 H Sung (652_CR1) 2021; 71 SH Ahn (652_CR29) 2019; 14 H Kim (652_CR13) 2020; 10 G Sharp (652_CR12) 2014; 41 A Rowcroft (652_CR4) 2020; 22 652_CR20 F Leymarie (652_CR9) 1993; 15 W Liu (652_CR11) 2019; 28 652_CR19 652_CR16 X Zhao (652_CR24) 2022; 12 D Zhang (652_CR35) 2020; 21 C Sperti (652_CR5) 1997; 21 T Vrtovec (652_CR30) 2020; 47 M Aloudat (652_CR10) 2019; 7 I Fornacon-Wood (652_CR27) 2020; 30 E Shelhamer (652_CR14) 2017; 39 E Chakraborty (652_CR7) 2022; 14 X Zhang (652_CR31) 2020; 10 A Hubert Beaumont (652_CR21) 2021; 31 MB Tayel (652_CR25) 2020; 16 X Liu (652_CR6) 2019; 24 R Mohammadi (652_CR28) 2021; 159 Z Peng (652_CR15) 2020; 47 P Lambin (652_CR17) 2012; 48 D Luo (652_CR26) 2021; 3 E Harding-Theobald (652_CR22) 2021; 54 J Zhao (652_CR23) 2021; 73 K Men (652_CR36) 2017; 44 VM Patel (652_CR32) 2015; 32 J Leporrier (652_CR3) 2006; 93 |
References_xml | – volume: 83 start-page: 278 year: 2021 ident: 652_CR34 publication-title: Phys Med doi: 10.1016/j.ejmp.2021.05.009 – volume: 7 start-page: 1 year: 2019 ident: 652_CR10 publication-title: IEEE J Translational Eng Health Med doi: 10.1109/JTEHM.2019.2915534 – volume: 12 start-page: 650797 year: 2022 ident: 652_CR24 publication-title: Front Oncol doi: 10.3389/fonc.2022.650797 – volume: 10 start-page: 6204 issue: 1 year: 2020 ident: 652_CR13 publication-title: Sci Rep doi: 10.1038/s41598-020-63285-0 – volume: 32 start-page: 53 issue: 3 year: 2015 ident: 652_CR32 publication-title: IEEE Signal Process Mag doi: 10.1109/MSP.2014.2347059 – volume: 10 start-page: 1621 year: 2020 ident: 652_CR31 publication-title: Front Oncol doi: 10.3389/fonc.2020.01621 – volume: 21 start-page: 158 issue: 10 year: 2020 ident: 652_CR35 publication-title: J Appl Clin Med Phys doi: 10.1002/acm2.13024 – volume: 7 start-page: 244 issue: 1 year: 2021 ident: 652_CR8 publication-title: Cell Death Discov doi: 10.1038/s41420-021-00634-6 – volume: 73 start-page: 102154 year: 2021 ident: 652_CR23 publication-title: Med Image Anal doi: 10.1016/j.media.2021.102154 – volume: 44 start-page: 6377 issue: 12 year: 2017 ident: 652_CR36 publication-title: Med Phys doi: 10.1002/mp.12602 – volume: 48 start-page: 441 issue: 4 year: 2012 ident: 652_CR17 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2011.11.036 – volume: 22 start-page: 497 issue: 4 year: 2020 ident: 652_CR4 publication-title: HPB (Oxford) doi: 10.1016/j.hpb.2019.11.002 – volume: 39 start-page: 640 issue: 4 year: 2017 ident: 652_CR14 publication-title: IEEE Trans Pattern Anal Mach Intell doi: 10.1109/TPAMI.2016.2572683 – ident: 652_CR20 doi: 10.1007/s00330-021-07877-y – volume: 24 start-page: 3 issue: Suppl 1 year: 2019 ident: 652_CR6 publication-title: Oncologist doi: 10.1634/theoncologist.2019-IO-S1-s01 – volume: 21 start-page: 195 issue: 2 year: 1997 ident: 652_CR5 publication-title: World J Surg doi: 10.1007/s002689900215 – volume: 14 start-page: 213 issue: 1 year: 2019 ident: 652_CR29 publication-title: Radiat Oncol doi: 10.1186/s13014-019-1392-z – volume: 41 start-page: 050902 issue: 5 year: 2014 ident: 652_CR12 publication-title: Med Phys doi: 10.1118/1.4871620 – volume: 30 start-page: 6241 issue: 11 year: 2020 ident: 652_CR27 publication-title: Eur Radiol doi: 10.1007/s00330-020-06957-9 – volume: 47 start-page: e929 issue: 9 year: 2020 ident: 652_CR30 publication-title: Med Phys doi: 10.1002/mp.14320 – volume: 28 start-page: 3766 issue: 8 year: 2019 ident: 652_CR11 publication-title: IEEE Trans Image Process doi: 10.1109/TIP.2019.2902784 – volume: 31 start-page: 6059 issue: 8 year: 2021 ident: 652_CR21 publication-title: Eur Radiol doi: 10.1007/s00330-020-07641-8 – volume: 71 start-page: 209 issue: 3 year: 2021 ident: 652_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 16 start-page: 611 issue: 5 year: 2020 ident: 652_CR25 publication-title: Curr Med Imaging doi: 10.2174/1573405615666190503142031 – volume: 15 start-page: 617 issue: 6 year: 1993 ident: 652_CR9 publication-title: IEEE Trans Pattern Anal Mach Intell doi: 10.1109/34.216733 – ident: 652_CR19 doi: 10.1007/s00330-018-5787-2 – volume: 286 start-page: 29 issue: 1 year: 2018 ident: 652_CR18 publication-title: Radiology doi: 10.1148/radiol.2017170554 – volume: 22 start-page: 5971 issue: 24 year: 2016 ident: 652_CR2 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-16-0460 – ident: 652_CR16 doi: 10.1023/A:1011174803800 – volume: 54 start-page: 890 issue: 7 year: 2021 ident: 652_CR22 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.16563 – volume: 14 start-page: 2798 issue: 11 year: 2022 ident: 652_CR7 publication-title: Cancers (Basel) doi: 10.3390/cancers14112798 – volume: 159 start-page: 231 year: 2021 ident: 652_CR28 publication-title: Radiother Oncol doi: 10.1016/j.radonc.2021.03.030 – volume: 13 start-page: e0205003 issue: 10 year: 2018 ident: 652_CR33 publication-title: PLoS ONE doi: 10.1371/journal.pone.0205003 – volume: 93 start-page: 465 issue: 4 year: 2006 ident: 652_CR3 publication-title: Br J Surg doi: 10.1002/bjs.5278 – volume: 47 start-page: 2526 issue: 6 year: 2020 ident: 652_CR15 publication-title: Med Phys doi: 10.1002/mp.14131 – volume: 3 start-page: 767836 year: 2021 ident: 652_CR26 publication-title: Front Med Technol doi: 10.3389/fmedt.2021.767836 |
SSID | ssj0029897 |
Score | 2.404275 |
Snippet | Background & aims
The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in... The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in hepatocellular... Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in... Background & aimsThe present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver tissue in... Abstract Background & aims The present study utilized extracted computed tomography radiomics features to classify the gross tumor volume and normal liver... |
SourceID | doaj proquest gale pubmed crossref springer |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 20 |
SubjectTerms | Accuracy Algorithms Automatic classification Calibration Cancer Research Chemotherapy Classification Computed tomography Correlation coefficients CT imaging CT radiomics Data mining Deep learning Diagnostic imaging Diagnostic systems Discrimination Hepatocellular carcinoma Hepatoma Imaging Liver Liver cancer Machine learning Medical imaging Medical research Medicine Medicine & Public Health Medicine, Experimental Nuclear Medicine Oncology Patients Radiology Radiomics Regression Research Article Software Statistical analysis Support vector machines Tumors |
SummonAdditionalLinks | – databaseName: DOAJ (Directory of Open Access Journals) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gBSMhcQCrediOfSwVVYVUTq3Um-VnWWk3qbrZv8Fv7oyTLF0QcOGaTKJkZjzf52QehLxvsa-U14HxGGCDkprAHGyEmJMhaBGVdAFrh8--ydML_vVSXN4Z9YU5YWN74FFxhxLwVUQPUGRLnoRzVXDAwkvnUqhSm6Nvqct5MzVttbTS7Vwio-ThGmCLcwZ4xBBza8Z3YCh36_89Jt8BpV_-kmbwOXlEHk6skR6NT_uY3IvdE3L_bPov_pT8OD6nNzYssMR4TRGZAu07Ok8_Gegq50xGOg2JuKJ5As6aAmWlHgn0Itc70St8WjpsVnB8DFzUdoF2yGyXdIlJHHTItqKLjn4HLBt6_PaPyazU41yirl_ZZ-Ti5Mv58SmbJi0wL1QzsOCFL20dUqyVDEkoz22Q3raSh8i5sN5ZYF4iSV4FC6xAgeqVS65uwKY2Nc_JXtd38SWhMsXEW6m9jg0Xdat943xSwBur0rZBF6SaFW_81IYcp2EsTd6OKGlGYxkwlsnGMrwgH7fXXI9NOP4q_RntuZXEBtr5ALiVmdzK_MutCvIWvcGM1ajbMGCOgFHhpDaU-JAlMBDAC3g71TOAGrCl1o7k_o4kLGC_e3r2ODMFkLWpNXBRCWROFeTd9jReiUlxXew3KAM34Mi6C_Ji9NTtSzcKVF81TUE-za778-Z_1t2r_6G71-RBnZdaxWq5T_aGm008AOo2uDd5ld4ChBc_Zg priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2ggJGQOIDVTeI4zgmViqVCKqdW6s3yc1lpNym72b_Bb2bGcVIWRK_JJIo9nvk-x_Mg5F2NdaVs4xj3DjYooXTMwEaIGeFcU3kpjMPc4bPv4vSCf7usLtMPt20Kqxx9YnTUrrP4j_yoaACcBaCb_HT1k2HXKDxdTS00bpM7eQFYi5ni86_ThquRQ3OVms9YBeA-Js1IcbQFIOOcAUIxROGC8T1givX7__XSf8DUX-emEY7mD8j9xCPp8aD4h-SWbx-Ru2fppPwx-XVyTjfaLTHpeEsRqxztWjr2Q-npOkZRepraRixo7ImzpUBiqUVKvYwZUHSBX0v73RquD66M6tbRFrnuiq4wrIP2UXt02dIfgG59h6cBGN5KLXYqaru1fkIu5l_OT05Z6r3AbCXLnjlb2ZkuXPCFFC5U0nLthNW14M5zXmlrNHCxKgieOw08QeahliaYogQt61A-JQdt1_rnhIrgA69FYxtf8qqoG1saGyQwyXyma9dkJB8nXtlUmBz7Y6xU3KBIoQZlKVCWispSPCMfpmeuhrIcN0p_Rn1OklhSO17oNguVLFQJIHKVt8B59IyHypjcGdjuzYwJDsZWZOQNrgY15KdOjkEdA8fC3m0o8T5KoGuAAVidMhxgGrDI1p7k4Z4kmLTdvz2uOJVcylZdG0BG3k638UkMk2t9t0MZeAFHHp6RZ8NKnQZdSpj6vCwz8nFcutcv___cvbj5W16Se0U0opwV4pAc9JudfwU0rTevoy3-BiT0OHs priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9QwDI5gkRAXxJvCAkZC4gAV0zZJ0-MyYrVCWk670t6iPJeRZlq00_kb_Gbs9MEOL4lr4kRNbMefm9hm7E1NeaVc43MePDoosfK5RUcot9L7RgQlrafY4dMv8uScf74QF2OaHIqFuX5_Xyj5YYsGh_McLUlO1rLM-U12S-DBS9K8lMvZuWpUU09BMX8ct2d4Un7-30_ha2bol3vRZG6O77G7I06Eo4Gx99mN0D5gt0_Hm_CH7PvyDK6MX1FQ8RbIFnnoWpjqnfSwSa8kA4xlIS4h1bzZAoJUcASZVynCCS7pa6HfbbB9OKrAtB5awrJrWNOzDegTd2DVwle0Xn1Hf_vp-So4qkTUdhvziJ0ffzpbnuRjbYXcCVX1uXfCLUzpYyiV9FEox42XztSS-8C5MM4axFoiSl54gzhAFbFWNtqyQi6aWD1mB23XhqcMZAyR17JxTai4KOvGVdZFhUixWJjaNxkrpo3Xbkw8TvUv1jo5IErqgVkamaUTszTP2Lt5zLch7cY_qT8SP2dKSpmdGlCS9KiBWiJQE8EhpjELHoW1hbfozi2sjR7XVmbsFUmDHuJPZ8XXR4ihqDYbUbxNFKT6uABnxggG3AZKorVHebhHiSrr9rsnidPjkbHVZYPoUyJ8Uxl7PXfTSHoG14ZuRzQ4ASecnbEng6TOi64Ubn1RVRl7P4nuz8n_vnfP_o_8ObtTJqUq8lIesoP-ahdeICzr7cukjz8At0Yvaw priority: 102 providerName: Springer Nature |
Title | CT radiomics based on different machine learning models for classifying gross tumor volume and normal liver tissue in hepatocellular carcinoma |
URI | https://link.springer.com/article/10.1186/s40644-024-00652-4 https://www.ncbi.nlm.nih.gov/pubmed/38279133 https://www.proquest.com/docview/2925660918 https://www.proquest.com/docview/2919740005 https://doaj.org/article/62735ec021a04f5bb1db8620bbfd1f72 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ri9NAEF_uAeIX8W31rCsIftBok2w2mw8id-XqIdwhcoV-W_ZZC22ibQr6T_g3O7N5aPUUvwSSTJbuzszOb7rzIORZjnWlTGEj5iw4KD61kQZHKNLc2iJzgmuLucPnF_xsyt7Pstke6dodtQu4udK1w35S0_Xy1dcv396Cwr8JCi_46w0YJcYisDYRWtQkYvvkMJwXYSgf608VsNh4aLbC8lGUgyPfJdFcOcaOoQr1_P_ctX8xW7-dowbzNLlJbrS4kh43gnCL7LnyNrl23p6c3yHfx5d0rewCk5A3FG2XpVVJu_4oNV2FqEpH2zYScxp65GwogFpqEGIvQkYUneOvpfV2Bc-brY2q0tISse-SLjHMg9aBm3RR0k9g7eoKTwcw3JUa7FxUVit1l0wnp5fjs6jtxRCZTKR1ZE1mRiqx3iWCW58Jw5TlRuWcWcdYpoxWgM0yz1lsFeAGEftcaK-TFLiufHqPHJRV6R4Qyr3zLOeFKVzKsiQvTKqNF4As45HKbTEgcbfw0rSFyrFfxlIGh0Vw2TBLArNkYJZkA_Ki_-ZzU6bjn9QnyM-eEktshwfVei5bjZUcgF3mDGAgNWI-0zq2Gty_kdbewtySAXmC0iCbfNV-o5DHgLmwlxtSPA8UKLwwAaPajAdYBiy6tUN5tEMJKm52X3cSJzsNkUkBaJUD3BMD8rR_jV9i2Fzpqi3SwAAMcfmA3G8ktZ90KmDp4zQdkJed6P4c_O9r9_C_J_WIXE-CPsVRwo_IQb3euseA4Go9JPv5LIermLwbksOT04sPH-FuzMfD8J_IMKjtD0ybRPI |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkIAXxH8KgxkJxANYaxLHcR4QGoOpY-ueOqlvxv9SJrXJaFMhvgQfhc_InZO0FMTe9ppcLNt3vt_vYp-PkJcZ3itlc8e4dxCgFIljBgIhZoRzeeqlMA5zh4enYnDGP4_T8Rb51eXC4LHKzicGR-0qi__I9-IcwFkAusn3F98YVo3C3dWuhEZjFsf-x3cI2Rbvjj6Cfl_F8eGn0cGAtVUFmE1lUjNnU9vXsSt8LIUrUmm5dsLqTHDnOU-1NRpYRloIHjkNCCijIpOmMHEC_ddFAu1eI9c5bjHC-snG6wAvl00xl4z3WQpkokvSkWJvAcDJOQNEZIj6MeMbQBjqBfyLCn_A4l_7tAH-Du-Q2y1vpfuNod0lW768R24M2535--TnwYjOtTvHJOcFRWx0tCppV3-lprNwatPTtkzFhIYaPAsKpJlapPDnIeOKTrC3tF7O4HnjOqkuHS2RW0_pFI-R0DpYCz0v6VdA07rC3Qc8TkstVkYqq5l-QM6uRCsPyXZZlf4xoaLwBc9EbnOf8DTOcpsYW0hgrlFfZy7vkaibeGXbi9CxHsdUhYBICtUoS4GyVFCW4j3yZvXNRXMNyKXSH1CfK0m8wjs8qOYT1XoEJYA4pt4Cx9J9XqTGRM5AeNk3pnAwtrhHdtEaVJMPu3JEah84HdaKQ4nXQQJdEQzA6jajAqYBL_XakNzZkAQXYjdfdxanWhe2UOsF1yMvVq_xSzyWV_pqiTLQAEfe3yOPGktdDTqRMPVRkvTI2850143_f-6eXN6XXXJzMBqeqJOj0-On5FYcFlTEYrFDtuv50j8Dilib52FdUvLlqh3Bb2iCd7k |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zb9QwELaglSpeUDkbWqiRkHiAqJvEcZzHpbAqC62QaKW-WT6XlXaTajf7N_jNzDgHXS6J13hsxR7PzDfyHIS8KrCulCltzJwFB8VnNtbgCMWaW1vmTnBtMXf4_IKfXbHpdX59K4s_RLv3T5JtTgNWaaqakxvrWxEX_GQNZoixGOxLjDY0jdldsivysgT3a3c8nn6dDk5XKcqiT5b548wtgxTq9v-unW-Zp1_eS4MZmuyT-x1-pOOW4Q_IHVc9JHvn3Qv5I_L99JKulJ1jsvGaoo2ytK5o3welocsQPelo1y5iRkMvnDUF8EoNQul5yHyiM_xb2myW8L1VYVRVllaIcRd0geEctAlco_OKfgOr1tT4CoBhrdRgh6KqXqrH5Gry4fL0LO56LsQmF1kTW5ObkUqtd6ng1ufCMGW5UQVn1jGWK6MVYLDcc5ZYBfhAJL4Q2us0A-4qnz0hO1VduQNCuXeeFbw0pctYnhalybTxAhBkMlKFLSOS9AcvTVeQHPtiLGRwTASXLbMkMEsGZkkWkTfDnJu2HMc_qd8hPwdKLKUdPtSrmewkU3IAcLkzgHXUiPlc68RqcPNGWnsLe0sjcoy3QbZ5qYNCkGPAVtizDSleBwpUCbABo7rMBjgGLK61RXm0RQmibLaH-xsnO1WylmkJqJQDrBMReTkM40wMj6tcvUEaWIAh_o7I0_amDpvOBBx9kmURedtf3Z-L__3snv0f-THZ-_J-Ij9_vPh0SO6lQb6SOOVHZKdZbdxzQG6NftEJ5w8FETwY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CT+radiomics+based+on+different+machine+learning+models+for+classifying+gross+tumor+volume+and+normal+liver+tissue+in+hepatocellular+carcinoma&rft.jtitle=Cancer+imaging&rft.au=Zhang%2C+Huai-wen&rft.au=Huang%2C+De-long&rft.au=Wang%2C+Yi-ren&rft.au=Zhong%2C+Hao-shu&rft.date=2024-01-26&rft.pub=BioMed+Central+Ltd&rft.issn=1470-7330&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs40644-024-00652-4&rft.externalDocID=A782197272 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1470-7330&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1470-7330&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1470-7330&client=summon |